68 related articles for article (PubMed ID: 22583615)
1. Induction of cell cycle arrest by GL331 via triggering an ATM-dependent DNA damage response in HepG2 cells.
Wang YJ; Chen XG; Xiao ZY; Liu GT; Sun H
J Asian Nat Prod Res; 2012; 14(7):657-64. PubMed ID: 22583615
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis and cell cycle arrest in glioma cells by GL331 (a topoisomerase II inhibitor).
Chen Y; Su YH; Wang CH; Wu JM; Chen JC; Tseng SH
Anticancer Res; 2005; 25(6B):4203-8. PubMed ID: 16309217
[TBL] [Abstract][Full Text] [Related]
3. Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation.
Wei F; Xie Y; Tao L; Tang D
Cell Signal; 2010 Nov; 22(11):1783-9. PubMed ID: 20637859
[TBL] [Abstract][Full Text] [Related]
4. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
5. Oxidative DNA damage is involved in ochratoxin A-induced G2 arrest through ataxia telangiectasia-mutated (ATM) pathways in human gastric epithelium GES-1 cells in vitro.
Cui J; Liu J; Wu S; Wang Y; Shen H; Xing L; Wang J; Yan X; Zhang X
Arch Toxicol; 2013 Oct; 87(10):1829-40. PubMed ID: 23515941
[TBL] [Abstract][Full Text] [Related]
6. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
7. 5-Methoxyflavanone induces cell cycle arrest at the G2/M phase, apoptosis and autophagy in HCT116 human colon cancer cells.
Shin SY; Hyun J; Yu JR; Lim Y; Lee YH
Toxicol Appl Pharmacol; 2011 Aug; 254(3):288-98. PubMed ID: 21616090
[TBL] [Abstract][Full Text] [Related]
8. GL331, a topoisomerase II inhibitor, induces radiosensitization of human glioma cells.
Chen Y; Lin TY; Chen JC; Yang HZ; Tseng SH
Anticancer Res; 2006; 26(3A):2149-56. PubMed ID: 16827158
[TBL] [Abstract][Full Text] [Related]
9. Etoposide and adriamycin but not genistein can activate the checkpoint kinase Chk2 independently of ATM/ATR.
Théard D; Coisy M; Ducommun B; Concannon P; Darbon JM
Biochem Biophys Res Commun; 2001 Dec; 289(5):1199-204. PubMed ID: 11741320
[TBL] [Abstract][Full Text] [Related]
10. PTEN enhances G2/M arrest in etoposide-treated MCF‑7 cells through activation of the ATM pathway.
Zhang R; Zhu L; Zhang L; Xu A; Li Z; Xu Y; He P; Wu M; Wei F; Wang C
Oncol Rep; 2016 May; 35(5):2707-14. PubMed ID: 26986476
[TBL] [Abstract][Full Text] [Related]
11. The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX.
Ye R; Goodarzi AA; Kurz EU; Saito S; Higashimoto Y; Lavin MF; Appella E; Anderson CW; Lees-Miller SP
DNA Repair (Amst); 2004 Mar; 3(3):235-44. PubMed ID: 15177039
[TBL] [Abstract][Full Text] [Related]
12. XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma.
Wang Y; Sun H; Xiao Z; Zhang D; Bao X; Wei N
Sci Rep; 2017 Aug; 7(1):9989. PubMed ID: 28855652
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of CDK2 from cyclin A in response to the topoisomerase II inhibitor etoposide in v-src-transformed but not normal NIH 3T3 cells.
Chen G; Hitomi M
Exp Cell Res; 1999 Jun; 249(2):327-36. PubMed ID: 10366432
[TBL] [Abstract][Full Text] [Related]
14. Regulation by survivin of cancer cell death induced by F14512, a polyamine-containing inhibitor of DNA topoisomerase II.
Ballot C; Jendoubi M; Kluza J; Jonneaux A; Laine W; Formstecher P; Bailly C; Marchetti P
Apoptosis; 2012 Apr; 17(4):364-76. PubMed ID: 22127645
[TBL] [Abstract][Full Text] [Related]
15. GL331 induces down-regulation of cyclin D1 expression via enhanced proteolysis and repressed transcription.
Lin S; Huang HC; Chen LL; Lee CC; Huang TS
Mol Pharmacol; 2001 Oct; 60(4):768-75. PubMed ID: 11562439
[TBL] [Abstract][Full Text] [Related]
16. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
[TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.
Yuan JH; Feng Y; Fisher RH; Maloid S; Longo DL; Ferris DK
Mol Cancer Res; 2004 Jul; 2(7):417-26. PubMed ID: 15280449
[TBL] [Abstract][Full Text] [Related]
18. G2 arrest in response to topoisomerase II inhibitors: the role of p53.
Clifford B; Beljin M; Stark GR; Taylor WR
Cancer Res; 2003 Jul; 63(14):4074-81. PubMed ID: 12874009
[TBL] [Abstract][Full Text] [Related]
19. ATM/ATR and SMAD3 pathways contribute to 3-indole-induced G₁ arrest in cancer cells and xenograft models.
Huang SM; Lu KT; Wang YC
Anticancer Res; 2011 Jan; 31(1):203-8. PubMed ID: 21273599
[TBL] [Abstract][Full Text] [Related]
20. Water-soluble oxoglaucine-Y(III), Dy(III) complexes: in vitro and in vivo anticancer activities by triggering DNA damage, leading to S phase arrest and apoptosis.
Wei JH; Chen ZF; Qin JL; Liu YC; Li ZQ; Khan TM; Wang M; Jiang YH; Shen WY; Liang H
Dalton Trans; 2015 Jul; 44(25):11408-19. PubMed ID: 26017376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
